Anúncio
Anúncio
PLRX
Pliant Therapeutics, Inc. Common Stock
1.32
USDPatrocinado
+0.01
+1.15%
09 de jan., 15:44 UTC -5
Encerrado
Pós-Mercado
1.32
0.00
-0.38%
Relatórios de Lucros PLRX
Rácio de surpresa positiva
PLRX separação 14 de 22 últimas estimativas.
64%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.40
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-6.98%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-51.22%
Pliant Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, PLRX reported earnings of -0.43 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 19.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.58% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an diminuir of -6.98% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Pliant Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pliant Therapeutics, Inc. Common Stock reported EPS of -$0.43, beating estimates by 19.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Pliant Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.58%, changed from $1.53 before the earnings release to $1.60 the day after.
When is Pliant Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Pliant Therapeutics, Inc. Common Stock's next earnings report?
Based on 9
analistas, Pliant Therapeutics, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio